Oligoprogression in Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Several retrospective studies present evidence of oligoprogressive disease (OPD) in patients with non-small cell lung cancer (NSCLC) with driver mutations such as EGFR. The strategy of local ablative therapy (LAT) with radiotherapy, followed by the continuation of the same anticancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Daijiro, Takigawa, Nagio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616478/
https://www.ncbi.nlm.nih.gov/pubmed/34830977
http://dx.doi.org/10.3390/cancers13225823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616478/
https://www.ncbi.nlm.nih.gov/pubmed/34830977
http://dx.doi.org/10.3390/cancers13225823

Ejemplares similares